E. Abreu, E. Aritonovska, P. Reichenbach, G. Cristofari, B. Culp et al., TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo, Mol. Cell. Biol, vol.30, pp.2971-2982, 2010.

S. K. Agarwal, S. C. Guru, C. Heppner, M. R. Erdos, R. M. Collins et al., , 1999.

, Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription, Cell, vol.96, pp.143-152

P. H. Aguiar, C. Furtado, B. M. Repolês, G. A. Ribeiro, I. C. Mendes et al., Oxidative stress and DNA lesions: the role of 8-oxoguanine lesions in Trypanosoma cruzi cell viability, PLoS Negl. Trop. Dis, vol.7, p.2279, 2013.

S. C. Akincilar, B. Unal, and V. Tergaonkar, Reactivation of telomerase in cancer, Cell. Mol. Life Sci, vol.73, pp.1659-1670, 2016.

M. Armanios, Syndromes of Telomere Shortening, Annu. Rev. Genomics Hum. Genet, vol.10, p.45, 2009.

M. Armanios and E. H. Blackburn, The telomere syndromes, Nat. Rev. Genet, vol.13, pp.693-704, 2012.

F. K. Askari and W. M. Mcdonnell, Antisense-Oligonucleotide Therapy, N. Engl. J. Med, vol.334, pp.316-318, 1996.

A. Augereau, C. T'kint-de-roodenbeke, T. Simonet, S. Bauwens, B. Horard et al., Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation, Blood, vol.118, pp.1316-1322, 2011.
URL : https://hal.archives-ouvertes.fr/ensl-00808485

D. J. Baker, T. Wijshake, T. Tchkonia, N. K. Lebrasseur, B. G. Childs et al., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders, Nature, vol.479, pp.232-236, 2011.

S. Balasubramanian, L. H. Hurley, N. , and S. , Targeting Gquadruplexees in gene promoters: a novel anticancer strategy?, Nat. Rev. Drug Discov, vol.10, pp.261-275, 2011.

J. Bernardes-de, B. Vera, E. Schneeberger, K. Tejera, A. M. Ayuso et al., Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer, EMBO Mol. Med, vol.4, pp.691-704, 2012.

K. Bisht, E. M. Smith, V. M. Tesmer, and J. Nandakumar, Structural and functional consequences of a disease mutation in the telomere protein TPP1, Proc. Natl. Acad. Sci. U. S. A, vol.113, pp.13021-13026, 2016.

P. F. Brunsvig, S. Aamdal, M. K. Gjertsen, G. Kvalheim, C. J. Markowski-grimsrud et al., Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer, Cancer Immunol. Immunother. CII, vol.55, pp.1553-1564, 2006.

A. M. Burger, F. Dai, C. M. Schultes, A. P. Reszka, M. J. Moore et al., The G-Quadruplexe-Interactive Molecule BRACO-19 Inhibits Tumor Growth, Consistent with Telomere Targeting and Interference with Telomerase Function, Cancer Res, vol.65, pp.1489-1496, 2005.

C. M. Buseman, W. E. Wright, and J. W. Shay, Is telomerase a viable target in cancer?, Mutat. Res, vol.730, pp.90-97, 2012.

A. J. Butt, C. M. Mcneil, E. A. Musgrove, and R. L. Sutherland, Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E, Endocr. Relat. Cancer, vol.12, pp.47-59, 2005.

C. E. Caldon, C. M. Sergio, J. Schütte, M. N. Boersma, R. L. Sutherland et al., Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc, Mol. Cell. Biol, vol.29, pp.4623-4639, 2009.

J. Chung, P. Khadka, C. , and I. K. , Nuclear import of hTERT requires a bipartite nuclear localization signal and Akt-mediated phosphorylation, J Cell Sci, vol.125, pp.2684-2697, 2012.

K. A. Cimprich, C. , and D. , ATR: an essential regulator of genome integrity, Nat. Rev. Mol. Cell Biol, vol.9, pp.616-627, 2008.

L. M. Colgin, C. Wilkinson, A. Englezou, A. Kilian, M. O. Robinson et al., The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity, vol.2, pp.426-432, 2000.

K. Collins, R. Kobayashi, and C. W. Greider, Purification of tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme, Cell, vol.81, pp.677-686, 1995.

D. Dai, T. Chen, J. Wanagat, M. Laflamme, D. J. Marcinek et al., Age-Dependent Cardiomyopathy in Mitochondrial Mutator Mice is Attenuated by Overexpression of Catalase Targeted to Mitochondria, Aging Cell, vol.9, pp.536-544, 2010.

T. De-lange, T-loops and the origin of telomeres, Nat. Rev. Mol. Cell Biol, vol.5, pp.323-329, 2004.

T. De-lange, How Telomeres Solve the End-Protection Problem, Science, vol.326, p.948, 2009.

W. Deng, G. Jayachandran, G. Wu, K. Xu, J. A. Roth et al., Tumorspecific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells, J. Biol. Chem, vol.282, pp.26460-26470, 2007.

T. R. Devereux, I. Horikawa, C. H. Anna, L. A. Annab, C. A. Afshari et al., DNA Methylation Analysis of the Promoter Region of the Human Telomerase Reverse Transcriptase (hTERT) Gene, Cancer Res, vol.59, pp.6087-6090, 1999.

H. Du, E. Pumbo, J. Ivanovich, P. An, R. T. Maziarz et al., TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements, Blood, vol.113, pp.309-316, 2009.

M. A. Dyer, Z. A. Qadeer, D. Valle-garcia, and E. Bernstein, ATRX and DAXX: Mechanisms and Mutations, Cold Spring Harb. Perspect. Med, vol.7, 2017.

K. T. Etheridge, S. S. Banik, B. N. Armbruster, Y. Zhu, R. M. Terns et al., The nucleolar localization domain of the catalytic subunit of human telomerase, J. Biol. Chem, vol.277, pp.24764-24770, 2002.

S. Ferrandon, P. Saultier, J. Carras, P. Battiston-montagne, G. Alphonse et al., Telomere Profiling: Toward Glioblastoma Personalized Medicine, Mol. Neurobiol, vol.47, pp.64-76, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00828504

A. Freund, F. L. Zhong, A. S. Venteicher, Z. Meng, T. D. Veenstra et al., Proteostatic control of telomerase function through TRiCmediated folding of TCAB1, Cell, vol.159, pp.1389-1403, 2014.

M. Garavís, C. González, and A. Villasante, On the Origin of the Eukaryotic Chromosome: The Role of Noncanonical DNA Structures in Telomere Evolution, 2013.

, Genome Biol. Evol, vol.5, pp.1142-1150

A. Ghosh, G. Saginc, S. C. Leow, E. Khattar, E. M. Shin et al., Telomerase directly regulates NF-?Bdependent transcription, Nat. Cell Biol, vol.14, pp.1270-1281, 2012.

D. Gomez, N. Aouali, A. Londoño-vallejo, L. Lacroix, F. Mégnin-chanet et al., , 2003.

, Resistance to the Short Term Antiproliferative Activity of the G-quadruplexe Ligand 12459 Is Associated with Telomerase Overexpression and Telomere Capping Alteration, J. Biol. Chem, vol.278, pp.50554-50562

D. Gomez, R. Paterski, T. Lemarteleur, K. Shin-ya, J. Mergny et al., Interaction of Telomestatin with the Telomeric Single-strand Overhang, J. Biol. Chem, 2004.

D. Gomez, T. Wenner, B. Brassart, C. Douarre, M. O'donohue et al., Telomestatininduced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells, J. Biol. Chem, vol.281, pp.38721-38729, 2006.

R. Gredilla, V. A. Bohr, and T. Stevnsner, Mitochondrial DNA repair and association with aging-an update, Exp. Gerontol, vol.45, pp.478-488, 2010.

C. W. Greider and E. H. Blackburn, Identification of a specific telomere terminal transferase activity in tetrahymena extracts, Cell, vol.43, pp.405-413, 1985.

K. G. Griewank, R. Murali, B. Schilling, T. Schimming, I. Möller et al., TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma, PLoS ONE, vol.8, 2013.

J. D. Griffith, L. Comeau, S. Rosenfield, R. M. Stansel, A. Bianchi et al., Mammalian Telomeres End in a Large Duplex Loop, Cell, vol.97, pp.503-514, 1999.

Ç. Günes, S. Lichtsteiner, A. P. Vasserot, and C. Englert, Expression of the hTERT Gene Is Regulated at the Level of Transcriptional Initiation and Repressed by Mad1, Cancer Res, vol.60, pp.2116-2121, 2000.

J. Haendeler, J. Hoffmann, R. P. Brandes, A. M. Zeiher, and S. Dimmeler, , 2003.

, Hydrogen Peroxide Triggers Nuclear Export of Telomerase Reverse Transcriptase via Src Kinase Family-Dependent Phosphorylation of Tyrosine 707, Mol. Cell. Biol, vol.23, pp.4598-4610

J. Haendeler, J. Hoffmann, S. Rahman, A. M. Zeiher, and S. Dimmeler, Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation, FEBS Lett, vol.536, pp.180-186, 2003.

J. Haendeler, S. Dröse, N. Büchner, S. Jakob, J. Altschmied et al., Mitochondrial Telomerase Reverse Transcriptase Binds to and Protects Mitochondrial DNA and Function From Damage, Arterioscler. Thromb. Vasc. Biol, vol.29, pp.929-935, 2009.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

L. S. Haneline, TERTrific hormones promote hematopoiesis, Blood, vol.114, pp.2207-2208, 2009.

R. Hänsel-hertsch, M. D. Antonio, and S. Balasubramanian, DNA Gquadruplexees in the human genome: detection, functions and therapeutic potential, Nat. Rev. Mol. Cell Biol, 2017.

C. B. Harley, W. Liu, M. Blasco, E. Vera, W. H. Andrews et al., A Natural Product Telomerase Activator As Part of a Health Maintenance Program, Rejuvenation Res, vol.14, pp.45-56, 2011.

L. Harrington, C. Hull, J. Crittenden, and C. Greider, Gel Shift and UV Cross-linking Analysis of Tetrahymena Telomerase, J. Biol. Chem, vol.270, pp.8893-8901, 1995.

L. Harrington, T. Mcphail, V. Mar, W. Zhou, R. Oulton et al., A mammalian telomerase-associated protein, Science, vol.275, pp.973-977, 1997.

L. Hayflick, The limited in vitro lifetime of human diploid cell strains, Exp. Cell Res, vol.37, pp.614-636, 1965.

H. He, A. S. Multani, W. Cosme-blanco, H. Tahara, J. Ma et al., POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination, EMBO J, vol.25, pp.5180-5190, 2006.

H. He, Y. Wang, X. Guo, S. Ramchandani, J. Ma et al., Pot1b Deletion and Telomerase Haploinsufficiency in Mice Initiate an ATR-Dependent DNA Damage Response and Elicit Phenotypes Resembling Dyskeratosis Congenita, Mol. Cell. Biol, vol.29, pp.229-240, 2009.

J. D. Henson and R. R. Reddel, Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers, FEBS Lett, vol.584, pp.3800-3811, 2010.

C. Heppner, K. Y. Bilimoria, S. K. Agarwal, M. Kester, L. J. Whitty et al., The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NFkappaB-mediated transactivation, Oncogene, vol.20, pp.4917-4925, 2001.

B. Herbert, A. E. Pitts, S. I. Baker, S. E. Hamilton, W. E. Wright et al., Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.14276-14281, 1999.

S. E. Holt, D. L. Aisner, J. Baur, V. M. Tesmer, M. Dy et al., Functional requirement of p23 and Hsp90 in telomerase complexes, Genes Dev, vol.13, p.817, 1999.

R. Hrdlicková, J. Nehyba, and H. R. Bose, Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation, Mol. Cell. Biol, vol.32, pp.4283-4296, 2012.

T. Hussain, S. Gupta, V. M. Adhami, and H. Mukhtar, Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells, Int. J. Cancer, vol.113, pp.660-669, 2005.

H. Hwang, A. Kreig, J. Calvert, J. Lormand, Y. Kwon et al., Telomeric overhang length determines structural dynamics and accessibility to telomerase and ALT associated proteins, Struct. Lond. Engl, vol.22, pp.842-853, 1993.

S. Iachettini, M. F. Stevens, M. Frigerio, M. G. Hummersone, I. Hutchinson et al., On and offtarget effects of telomere uncapping G-quadruplexe selective ligands based on pentacyclic acridinium salts, J. Exp. Clin. Cancer Res. CR, vol.32, p.68, 2013.

M. A. Jafri, S. A. Ansari, M. H. Alqahtani, and J. W. Shay, Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies, Genome Med, vol.8, 2016.

B. B. De-jesus, K. Schneeberger, E. Vera, A. Tejera, C. B. Harley et al., The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence, Aging Cell, vol.10, pp.604-621, 2011.

R. W. Johnstone, Histone-deacetylase inhibitors: novel drugs for the treatment of cancer, Nat. Rev. Drug Discov, vol.1, pp.287-299, 2002.

P. A. Jones, Functions of DNA methylation: islands, start sites, gene bodies and beyond, Nat. Rev. Genet, vol.13, pp.484-492, 2012.

S. S. Kang, T. Kwon, D. Y. Kwon, and S. I. Do, Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit, J. Biol. Chem, vol.274, pp.13085-13090, 1999.

J. Karijolich, C. Yi, Y. , and Y. , Transcriptome-wide dynamics of RNA pseudouridylation, Nat. Rev. Mol. Cell Biol, vol.16, pp.581-585, 2015.

A. K. Khaw, M. P. Hande, G. Kalthur, and M. P. Hande, Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells, J. Cell. Biochem, vol.114, pp.1257-1270, 2013.

A. Khoshnan, C. Tindell, I. Laux, D. Bae, B. Bennett et al., The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes, J. Immunol. Baltim. Md, vol.165, pp.1743-1754, 1950.

T. Kibe, G. A. Osawa, C. E. Keegan, T. Lange, and . De, Telomere Protection by TPP1 Is Mediated by POT1a and POT1b, Mol. Cell. Biol, vol.30, pp.1059-1066, 2010.

A. Kilian, D. D. Bowtell, H. E. Abud, G. R. Hime, D. J. Venter et al., Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types, Hum. Mol. Genet, vol.6, pp.2011-2019, 1997.

J. E. Kokoszka, P. Coskun, L. A. Esposito, W. , and D. C. , Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.2278-2283, 2001.

M. Koshiji, Y. Kageyama, E. A. Pete, I. Horikawa, J. C. Barrett et al., HIF-1alpha induces cell cycle arrest by functionally counteracting Myc, EMBO J, vol.23, pp.1949-1956, 2004.
DOI : 10.1038/sj.emboj.7600196

URL : http://emboj.embopress.org/content/23/9/1949.full.pdf

S. Kyo, M. Takakura, T. Taira, T. Kanaya, H. Itoh et al., Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT), Nucleic Acids Res, vol.28, pp.669-677, 2000.

J. A. Kyte, Cancer vaccination with telomerase peptide GV1001, Expert Opin. Investig. Drugs, vol.18, pp.687-694, 2009.
DOI : 10.1517/13543780902897631

J. D. Legassie and M. B. Jarstfer, The unmasking of telomerase, Struct. Lond. Engl, vol.14, pp.1603-1609, 1993.

G. M. Leinninger, J. L. Edwards, M. J. Lipshaw, and E. L. Feldman, Mechanisms of Disease: mitochondria as new therapeutic targets in diabetic neuropathy, Nat. Rev. Neurol, vol.2, pp.620-628, 2006.

S. Y. Lin and S. J. Elledge, Multiple tumor suppressor pathways negatively regulate telomerase, Cell, vol.113, pp.881-889, 2003.
DOI : 10.1016/s0092-8674(03)00430-6

URL : https://doi.org/10.1016/s0092-8674(03)00430-6

I. Listerman, J. Sun, F. S. Gazzaniga, J. L. Lukas, and E. H. Blackburn, The major reverse-transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis, Cancer Res, vol.73, pp.2817-2828, 2013.

C. Liu, X. Fang, Z. Ge, M. Jalink, S. Kyo et al., The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3, Cancer Res, vol.67, pp.2626-2631, 2007.

T. Liu, X. Yuan, and D. Xu, Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications, Genes, vol.7, 2016.
DOI : 10.3390/genes7070038

URL : https://www.mdpi.com/2073-4425/7/7/38/pdf

Y. Maida, S. Kyo, T. Kanaya, Z. Wang, N. Yatabe et al., Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway, Oncogene, vol.21, pp.4071-4079, 2002.

Y. Maida, M. Yasukawa, M. Furuuchi, T. Lassmann, R. Possemato et al., An RNA dependent RNA polymerase formed by hTERT and the RNase MRP RNA, Nature, vol.461, pp.230-235, 2009.

P. Martínez and M. A. Blasco, Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins, Nat. Rev. Cancer, vol.11, pp.161-176, 2011.

P. Martínez, M. Thanasoula, P. Muñoz, C. Liao, A. Tejera et al., Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice, Genes Dev, vol.23, pp.2060-2075, 2009.

J. Mergny and C. Hélène, G-quadruplexe DNA: A target for drug design, Nat. Med, vol.4, pp.1366-1367, 1998.

J. Mergny, L. Lacroix, M. Teulade-fichou, C. Hounsou, L. Guittat et al., , 2001.

, Telomerase inhibitors based on quadruplexe ligands selected by a fluorescence assay, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.3062-3067

J. R. Mitchell, E. Wood, C. , and K. , A telomerase component is defective in the human disease dyskeratosis congenita, Nature, vol.402, pp.551-555, 1999.

G. B. Morin, The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats, Cell, vol.59, pp.521-529, 1989.
DOI : 10.1016/0092-8674(89)90035-4

I. Naasani, F. Oh-hashi, T. Oh-hara, W. Y. Feng, J. Johnston et al., Blocking Telomerase by Dietary Polyphenols Is a Major Mechanism for Limiting the Growth of Human Cancer Cells in Vitro and in Vivo, Cancer Res, vol.63, pp.824-830, 2003.

J. Nakayama, M. Saito, H. Nakamura, A. Matsuura, and F. Ishikawa, TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family, Cell, vol.88, pp.875-884, 1997.

J. Nandakumar and T. R. Cech, Finding the end: recruitment of telomerase to telomeres, Nat. Rev. Mol. Cell Biol, vol.14, pp.69-82, 2013.

D. Neuhof, A. Ruess, F. Wenz, and K. J. Weber, Induction of telomerase activity by irradiation in human lymphoblasts, Radiat. Res, vol.155, pp.693-697, 2001.

J. C. Norton, M. A. Piatyszek, W. E. Wright, J. W. Shay, C. et al., Inhibition of human telomerase activity by peptide nucleic acids, Nat. Biotechnol, vol.14, pp.615-619, 1996.

L. Oganesian and J. Karlseder, Telomeric armor: the layers of end protection, J. Cell Sci, vol.122, pp.4013-4025, 2009.

R. J. O'sullivan and J. Karlseder, Telomeres: protecting chromosomes against genome instability, Nat. Rev. Mol. Cell Biol, vol.11, pp.171-181, 2010.

J. Park, A. S. Venteicher, J. Y. Hong, J. Choi, S. Jun et al., Telomerase modulates Wnt signalling by association with target gene chromatin, Nature, vol.460, pp.66-72, 2009.

S. D. Perrault, P. J. Hornsby, and D. H. Betts, Global gene expression response to telomerase in bovine adrenocortical cells, Biochem. Biophys. Res. Commun, vol.335, pp.925-936, 2005.

A. Pestana, J. Vinagre, M. Sobrinho-simões, and P. Soares, TERT biology and function in cancer: beyond immortalization, J. Mol. Endocrinol. JME, pp.16-0195, 2017.

E. Pezzato, L. Sartor, I. Dell'aica, R. Dittadi, M. Gion et al., Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3gallate, Int. J. Cancer, vol.112, pp.787-792, 2004.

Y. Qin, H. Guo, B. Tang, Y. , and S. , The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review), Int. J. Oncol, vol.45, pp.525-531, 2014.

M. A. Read, N. , and S. , Structural characterization of a guaninequadruplexe ligand complex, Biochemistry (Mosc.), vol.39, pp.13422-13432, 2000.

D. Rhodes and H. J. Lipps, G-quadruplexees and their regulatory roles in biology, Nucleic Acids Res, vol.43, pp.8627-8637, 2015.

A. R. Robart, C. , and K. , Networked Human Telomerase Domain Interactions Capture the Template-paired Substrate and Single-stranded Product for Processive Elongation, Mol. Cell, vol.42, p.308, 2011.

D. Sadava, E. Whitlock, K. , and S. E. , The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells, Biochem. Biophys. Res. Commun, vol.360, pp.233-237, 2007.

S. Saebøe-larssen, E. Fossberg, and G. Gaudernack, Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues, BMC Mol. Biol, vol.7, p.26, 2006.

E. Sahin, S. Colla, M. Liesa, J. Moslehi, F. L. Müller et al., Telomere dysfunction induces metabolic and mitochondrial compromise, Nature, vol.470, pp.359-365, 2011.

Y. Saito, H. Fujimoto, and J. Kobayashi, Role of NBS1 in DNA damage response and its relationship with cancer development, Transl. Cancer Res, vol.2, pp.178-189, 2013.

J. H. Santos, J. N. Meyer, M. Skorvaga, L. A. Annab, and B. Van-houten, , 2004.

, Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage, Aging Cell, vol.3, pp.399-411

J. C. Schmidt, A. B. Dalby, and T. R. Cech, Identification of human TERT elements necessary for telomerase recruitment to telomeres, vol.3

H. Seimiya, H. Sawada, Y. Muramatsu, M. Shimizu, K. Ohko et al., Involvement of 14-3-3 proteins in nuclear localization of telomerase, EMBO J, vol.19, p.2652, 2000.

A. Sfeir, S. T. Kosiyatrakul, D. Hockemeyer, S. L. Macrae, J. Karlseder et al., Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication, Cell, vol.138, p.90, 2009.
DOI : 10.1016/s9999-9994(09)20370-9

N. K. Sharma, A. Reyes, P. Green, M. J. Caron, M. G. Bonini et al., Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria, Nucleic Acids Res, vol.40, pp.712-725, 2012.
DOI : 10.1093/nar/gkr758

URL : https://academic.oup.com/nar/article-pdf/40/2/712/16959677/gkr758.pdf

K. Shin, M. K. Kang, E. Dicterow, and N. Park, Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes, Br. J. Cancer, vol.89, pp.1473-1478, 2003.

K. Shin-ya, K. Wierzba, K. Matsuo, T. Ohtani, Y. Yamada et al., Telomestatin, a Novel Telomerase Inhibitor from Streptomyces anulatus, J. Am. Chem. Soc, vol.123, pp.1262-1263, 2001.

Y. Souiden, A. Bouraoui, K. Chaieb, and K. Mahdouani, Télomères et télomérase comme cibles thérapeutiques dans le traitement du cancer, Bull. Cancer (Paris), vol.97, pp.1087-1104, 2010.

R. M. Stansel, T. De-lange, G. , and J. D. , T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang, EMBO J, vol.20, pp.5532-5540, 2001.

Z. Su, J. Dannull, B. K. Yang, P. Dahm, D. Coleman et al., Telomerase mRNAtransfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer, J. Immunol. Baltim. Md, vol.174, pp.3798-3807, 1950.
DOI : 10.4049/jimmunol.174.6.3798

URL : http://www.jimmunol.org/content/174/6/3798.full.pdf

D. Sun, B. Thompson, B. E. Cathers, M. Salazar, S. M. Kerwin et al., Inhibition of Human Telomerase by a G-Quadruplexe-Interactive Compound, J. Med. Chem, vol.40, pp.2113-2116, 1997.
DOI : 10.1021/jm970199z

K. K. Takai, S. Hooper, S. Blackwood, R. Gandhi, and T. De-lange, In Vivo Stoichiometry of Shelterin Components, J. Biol. Chem, vol.285, pp.1457-1467, 2010.
DOI : 10.1074/jbc.m109.038026

URL : http://www.jbc.org/content/285/2/1457.full.pdf

M. Takakura, S. Kyo, Y. Sowa, Z. Wang, N. Yatabe et al., Telomerase activation by histone deacetylase inhibitor in normal cells, Nucleic Acids Res, vol.29, pp.3006-3011, 2001.
DOI : 10.1093/nar/29.14.3006

URL : https://academic.oup.com/nar/article-pdf/29/14/3006/9905967/293006.pdf

A. M. Tejera, M. S. Alcontres, M. Thanasoula, R. M. Marion, P. Martinez et al., TPP1 Is Required for TERT Recruitment, Telomere Elongation during Nuclear Reprogramming, and Normal Skin Development in Mice, Dev. Cell, vol.18, p.775, 2010.
DOI : 10.1016/j.devcel.2010.03.011

URL : https://doi.org/10.1016/j.devcel.2010.03.011

N. Temime-smaali, L. Guittat, A. Sidibe, K. Shin-ya, C. Trentesaux et al., The G-quadruplexe ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplexe-forming oligonucleotides and uncaps telomeres in ALT cells, PloS One, vol.4, p.6919, 2009.

A. Trifunovic, A. Wredenberg, M. Falkenberg, J. N. Spelbrink, A. T. Rovio et al., Premature ageing in mice expressing defective mitochondrial DNA polymerase, Nature, vol.429, pp.417-423, 2004.
DOI : 10.1038/nature02517

E. Varela, M. A. Muñoz-lorente, A. M. Tejera, S. Ortega, and M. A. Blasco, Generation of mice with longer and better preserved telomeres in the absence of genetic manipulations, Nat. Commun, vol.7, 2016.

A. S. Venteicher, E. B. Abreu, Z. Meng, K. E. Mccann, R. M. Terns et al., A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis, Science, vol.323, pp.644-648, 2009.
DOI : 10.1126/science.1165357

URL : http://europepmc.org/articles/pmc2728071?pdf=render

J. Vinagre, A. Almeida, H. Pópulo, R. Batista, J. Lyra et al., Frequency of TERT promoter mutations in human cancers, Nat. Commun, vol.4, p.2185, 2013.
DOI : 10.1038/ncomms3185

URL : https://www.nature.com/articles/ncomms3185.pdf

T. J. Vulliamy, M. J. Kirwan, R. Beswick, U. Hossain, C. Baqai et al., Differences in Disease Severity but Similar Telomere Lengths in Genetic Subgroups of Patients with Telomerase and Shelterin Mutations, PLoS ONE, vol.6, 2011.

F. Wang, E. R. Podell, A. J. Zaug, Y. Yang, P. Baciu et al., The POT1-TPP1 telomere complex is a telomerase processivity factor, Nature, vol.445, pp.506-510, 2007.
DOI : 10.1038/nature05454

F. Wang, E. R. Podell, A. J. Zaug, Y. Yang, P. Baciu et al., The POT1-TPP1 telomere complex is a telomerase processivity factor, Nature, vol.445, pp.506-510, 2007.
DOI : 10.1038/nature05454

M. Wick, D. Zubov, H. , and G. , Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT), Gene, vol.232, pp.97-106, 1999.

, The Lewis Lab, Wisconsin Institude for Discovery, 2013.

J. Won, J. Yim, K. , and T. K. , Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells, J. Biol. Chem, vol.277, pp.38230-38238, 2002.

M. S. Wong, W. E. Wright, and J. W. Shay, Alternative Splicing Regulation of Telomerase: A New Paradigm, Trends Genet. TIG, vol.30, pp.430-438, 2014.

M. S. Wong, J. W. Shay, W. , and W. E. , Regulation of human telomerase splicing by RNA:RNA pairing, Nat. Commun, vol.5, 2014.

K. Wu, C. Grandori, M. Amacker, N. Simon-vermot, A. Polack et al., Direct activation of TERT transcription by c-MYC, Nat. Genet, vol.21, pp.220-224, 1999.

R. A. Wu, H. E. Upton, J. M. Vogan, C. , and K. , Telomerase Mechanism of Telomere Synthesis, Annu. Rev. Biochem, vol.86, 2017.

Y. Xu, H. Sato, K. Shinohara, M. Komiyama, and H. Sugiyama, T-loop formation by human telomeric G-quadruplexe, Nucleic Acids Symp. Ser, vol.51, pp.243-244, 2007.

O. Yamada, K. Ozaki, M. Akiyama, and K. Kawauchi, JAK-STAT and JAKPI3K-mTORC1 Pathways Regulate Telomerase Transcriptionally and Posttranslationally in ATL Cells, Mol. Cancer Ther, vol.11, pp.1112-1121, 2012.

H. Yamaguchi, R. T. Calado, H. Ly, S. Kajigaya, G. M. Baerlocher et al., Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia, N. Engl. J. Med, vol.352, pp.1413-1424, 2005.

N. Yang and H. H. Kazazian, L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells, Nat. Struct. Mol. Biol, vol.13, pp.763-771, 2006.

H. Yang, S. Kyo, M. Takatura, and L. Sun, Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells, Cell Growth Differ. Mol. Biol. J. Am. Assoc. Cancer Res, vol.12, pp.119-127, 2001.

Y. Yao, M. Bellon, S. N. Shelton, and C. Nicot, Tumor Suppressors p53, p63TA?, p63TAy, p73?, and p73? Use Distinct Pathways to Repress Telomerase Expression, J. Biol. Chem, vol.287, p.20737, 2012.

N. Yatabe, S. Kyo, Y. Maida, H. Nishi, M. Nakamura et al., HIF-1-mediated activation of telomerase in cervical cancer cells, Oncogene, vol.23, pp.3708-3715, 2004.

X. Yi, J. W. Shay, W. , and W. E. , Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells, Nucleic Acids Res, vol.29, pp.4818-4825, 2001.

L. Yin, A. K. Hubbard, and C. Giardina, NF-?B Regulates Transcription of the Mouse Telomerase Catalytic Subunit, J. Biol. Chem, vol.275, pp.36671-36675, 2000.

A. J. Zaug, E. R. Podell, J. Nandakumar, and T. R. Cech, Functional interaction between telomere protein TPP1 and telomerase, Genes Dev, pp.613-622, 2010.

Y. Zhang, L. Chen, X. Han, W. Xie, H. Kim et al., Phosphorylation of TPP1 regulates cell cycle-dependent telomerase recruitment, Proc. Natl. Acad. Sci. U. S. A, vol.110, pp.5457-5462, 2013.

F. L. Zhong, L. F. Batista, A. Freund, M. F. Pech, A. S. Venteicher et al., TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends, Cell, vol.150, pp.481-494, 2012.

Y. Zhong, Z. Liao, F. Zhou, C. Xie, C. Xiao et al., Telomere length inversely correlates with radiosensitivity in human carcinoma cells with the same tissue background, Biochem. Biophys. Res. Commun, vol.367, pp.84-89, 2008.

G. Zhou, X. Liu, Y. Li, S. Xu, C. Ma et al., Telomere targeting with a novel G-quadruplexe-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells, Oncotarget, vol.7, pp.14925-14939, 2016.

F. Lorraine,

. Demal"ide-d'-lmprima-t-ur-o, , p.11, 2017.

D. En-pharmacie-p and ;. Eleo,

. Dumair-·-mme and . Dcj,

H. Mcu-l&apos;h-j&quot;i-;-m-alcundrc, 1CU.PH \1 E;;;ma;met RANFAl).;G, Phomatlell VucUpp<OU~ Nucy, lc ZIA, 08. ~">?+°"7<D de Il F1cul:t ck Plwmlc

L. Pmidcnt and ~. Ouec,

. Nij, . Eu&apos;iwic:fr, and . Vu, , 2017.